Lara Sullivan serves as Executive at Pyxis Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Lara Sullivan has executed 11 insider transactions totaling $81.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 18, 2023 involved selling 8,541 shares valued at $17.9K.
Lara Sullivan currently holds 2,403,882 shares of Pyxis Oncology, Inc. (PYXS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lara Sullivan has been a net seller of PYXS stock. They have purchased $0 and sold $81.4K worth of shares.
Lara Sullivan's most recent insider trade was on Sep 18, 2023, when they sold 8,541 shares at $2.10 per share.
Get notified when new Form 4 filings are submitted
| $2.25 |
| Discretionary |
| Sep 13, 2023 | PYXS | $393.5K | Payment | 184,742 | $2.13 | Discretionary |
| Sep 13, 2023 | PYXS | $6.8K | Sale | 3,000 | $2.27 | Discretionary |
| Sep 12, 2023 | PYXS | $11.1K | Sale | 4,917 | $2.25 | Discretionary |
| Sep 11, 2023 | PYXS | $45.4K | Sale | 20,000 | $2.27 | Discretionary |
| Sep 7, 2023 | PYXS | $0 | Award | 469,483 | $N/A | Discretionary |
| Mar 24, 2023 | PYXS | $0 | Award | 703,379 | $N/A | Discretionary |
| Jan 3, 2023 | PYXS | $0 | Award | 95,684 | $N/A | Discretionary |
| Apr 14, 2022 | PYXS | $0 | Award | 315,273 | $N/A | Discretionary |
| Mar 31, 2022 | PYXS | $0 | Award | 742,574 | $N/A | Discretionary |